Elomatic-Pharmalab Consulting And Engineering Private Limited, a active private limited company, was established on 27 October 2004 in Thane West, Maharashtra, India. Engaging in procurement & construction (epc) within the professional, scientific and technical sector, it holds CIN: U73100MH2004PTC149278. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹7.50 Cr and a paid-up capital of ₹5.17 Cr.
It upholds a compliant status. Its leadership includes Vishal Umesh Shah (Director), Umesh Purushottam Shah (Director), Mona Akerholm Daniela (Director). Past directors included Nitin Purushottam Shah, Vishal Umesh Shah, Ted Roger Bergman. It holds no open charges and ₹6.04 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Centrum, Unit No. 301 To 304, Opp. Tmc Office Next To Satkar Grande Hotel, Waghle Indl, Estate,, Thane West, Maharashtra, 400604.
U73100MH2004PTC149278
149278
27 October 2004
₹7.50 Cr
₹5.17 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Elomatic-Pharmalab Consulting And Engineering Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vishal Umesh Shah | Director | 11 Aug 2020 | Current |
| Umesh Purushottam Shah | Director | 27 Oct 2004 | Current |
| Mona Akerholm Daniela | Director | 21 Apr 2022 | Current |
| Tom Henrik Lind | Director | 30 Jul 2024 | Current |
| Tero Seppo Juhani Tuomela | Director | 30 Sep 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 13 Aug 2020 | Past |
| Pramod Abcsdd | Additional Director | 28 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 21 Apr 2022 | Past |
| Pramod Abcsdd | Additional Director | 28 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2022 | Past |
| Pramod Abcsdd | Director | 07 Aug 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Elomatic-Pharmalab Consulting And Engineering Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.67% increase. The company also saw a substantial fall in profitability, with a 19.63% decrease in profit. The company's net worth Soared by an impressive increase of 20.35%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Elomatic-Pharmalab Consulting And Engineering had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹6,040,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jun 2021 | Canara Bank | ₹0.74 M | Satisfied |
| 05 Mar 2014 | Canara Bank | ₹2.50 M | Satisfied |
| 17 Feb 2014 | Canara Bank | ₹2.50 M | Satisfied |
| 01 Nov 2007 | Canara Bank | ₹0.30 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Elomatic-Pharmalab Consulting And Engineering, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Elomatic-Pharmalab Consulting And Engineering, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elomatic-Pharmalab Consulting And Engineering's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Elomatic-Pharmalab Consulting And Engineering Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Tom Henrik Lind was appointed as a Director was appointed as a Director on 30 Jul 2024 & has been associated with this company since 1 year 4 months . was documented.
Progress on Elomatic-Pharmalab Consulting And Engineering Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity A charge registered on 05 Mar 2014 via Charge ID 10483442 with Canara Bank was fully satisfied on 16 Oct 2023. was completed.
A charge registered on 17 Feb 2014 via Charge ID 10481305 with Canara Bank was fully satisfied on 16 Oct 2023. was recorded as a recent event.
The activity A charge registered on 01 Nov 2007 via Charge ID 10074841 with Canara Bank was fully satisfied on 16 Oct 2023. was completed.
The CIN of Elomatic-Pharmalab Consulting And Engineering Private Limited is U73100MH2004PTC149278.
Elomatic-Pharmalab Consulting And Engineering Private Limited is headquartered at Centrum, Unit No. 301 To 304, Opp. Tmc Office Next To Satkar Grande Hotel, Waghle Indl, Estate,, Thane West, Maharashtra, 400604.
Elomatic-Pharmalab Consulting And Engineering Private Limited was incorporated on 27 October 2004.
The current directors of Elomatic-Pharmalab Consulting And Engineering Private Limited are
The primary industry of Elomatic-Pharmalab Consulting And Engineering Private Limited is Professional, Scientific And Technical.
Elomatic-Pharmalab Consulting And Engineering Private Limited is unlisted.
The authorized capital of Elomatic-Pharmalab Consulting And Engineering Private Limited is ₹7.50 Cr, and the paid-up capital is ₹5.17 Cr.
The compliance status of Elomatic-Pharmalab Consulting And Engineering Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX